What is it about?
Lipid-lowering therapy is an essential part of CVD prevention plan for patients with T2DM. It is necessary to assess the prescribing quality and the extent of effectiveness of these prescribed medications to optimize CVD prevention plans.
Featured Image
Why is it important?
We assessed the quality of prescribing these medications in the primary care setting. Also, we assessed the overall percentage of the study population who achieved target LDL-C levels. Finally, we identified factors associated with both quality prescribing and effectiveness.
Read the Original
This page is a summary of: Effectiveness and prescription pattern of lipid-lowering therapy and its associated factors among patients with type 2 diabetes mellitus in Malaysian primary care settings, Therapeutics and Clinical Risk Management, January 2019, Dove Medical Press,
DOI: 10.2147/tcrm.s182716.
You can read the full text:
Contributors
The following have contributed to this page
